The aPTT assay as a monitor of heparin anticoagulation efficacy in clinical settings |
| |
Authors: | Chih-Cheng Chen Jie-Yu You Chao-Hung Ho |
| |
Institution: | (1) Division of Hematology Department of Internal Medicine Veterans General Hospital-Taipei, National Yang-Ming University School of Medicine, Taipei, Taiwan |
| |
Abstract: | Activated partial thromboplastin time (aPTT) and prothrombin time (PT) are 2 major methods of screening patients for bleeding
tendency. Heparin is an anticoagulant commonly used for various clinical conditions and will thus affect the coagulation profile.
The influence of heparin on PT vs aPTT, seldom addressed in the past, should be carefully investigated. Prospective data on
35 patients who were heparinized for clinically indicated conditions were collected and analyzed for the change in PT (dPT)
and aPTT (daPTT) at 3 time points after treatment, all of which were compared with baseline data checked before therapy. Age,
sex, and the results of a complete blood count and liver and renal function tests were also evaluated for each patient to
determine their effects on dPT and daPTT. The therapeutic goal of keeping the aPTT within a desirable range was achieved in
∼75% of patients by the last day of heparin therapy. Within this range, dPTs were not statistically significant, nor was the
effect of age, sex, hemoglobin level, serum albumin level, white cell count, platelet count, or renal or hepatic function.
In patients with thrombosis, dPT was not significantly influenced by heparin dose. During an overlap in the periods of coumadin
and heparin administration, PT was used as a guide for adjusting the coumadin dose. The anticoagulant effect, indicated by
a PT in the target range, would occur primarily secondary to coumadin administration and would make it relatively easy to
decide when to discontinue heparin. |
| |
Keywords: | heparin coumadin activated partial thromboplastin time prothrombin time aPTT PT |
本文献已被 PubMed SpringerLink 等数据库收录! |
|